The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children

• Main Authors: Gholamreza Panahandeh, Bahareh Vatani, Parvin Safavi, Abolfazl Khoshdel
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2017-01-01
• Series: Journal of Advanced Pharmaceutical Technology & Research
• Subjects: Attention-deficit/hyperactivity disorder; ferrous sulfate; methylphenidate
• Online Access: http://www.japtr.org/article.asp?issn=2231-4040;year=2017;volume=8;issue=4;spage=138;epage=142;aulast=Panahandeh
• ISSN: 2231-4040; 0976-2094

Attention deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders in children with several complications. This study was conducted to investigate the effect of adding ferrous sulfate to methylphenidate in decreasing ADHD symptoms. This study was a double-blind, randomized clinical trial. In this study, 42 nonanemic children with ADHD and serum ferritin below 30 mg/ml were enrolled according to convenience sampling and randomly assigned to two groups of 21 each, cases and controls. The two groups were matched for age and sex. The case group was administered with ferrous sulfate 5 mg/kg in addition to methylphenidate up to 1 mg/kg and the control group with methylphenidate alone. The scores on child symptoms inventory-4 (CSI-4) were recorded at baseline and after 2 months of treatment. Data were analyzed by t-test, Pearson's correlation coefficient, and repeated measures ANOVA in SPSS 16. The scores on CSI-4 decreased significantly at month 2 in both groups (P < 0.001). The scores on attention deficit and hyperactivity subscales of the CSI-4 were significantly lower in the case group than the control group (P < 0.05). The total score on CSI-4 decreased more markedly in the case group (P < 0.04). Use of ferrous sulfate plus methylphenidate can be effective in reducing ADHD symptoms in nonanemic children with low serum ferritin.